Verastem, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Verastem, Inc. (VSTM) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $165.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-07
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $165.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $220.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $310.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $165.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $220.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $310.00K 10-Q · filed 2018-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |